Cargando…
Dexamethasone for the Treatment of Coronavirus Disease (COVID-19): a Review
The World Health Organization (WHO) declared COVID-19 (novel coronavirus) as a global pandemic in the middle of March 2020, after the disease spread to more than 150 countries and territories leading to tens of thousands of cases within a couple of months. To date, there are no effective pharmaceuti...
Autores principales: | Ahmed, Mukhtar H., Hassan, Arez |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599121/ https://www.ncbi.nlm.nih.gov/pubmed/33163859 http://dx.doi.org/10.1007/s42399-020-00610-8 |
Ejemplares similares
-
Systematic and Statistical Review of Coronavirus Disease 19 Treatment Trials
por: Siordia, Juan A., et al.
Publicado: (2020) -
Tocilizumab, Remdesivir, Favipiravir, and Dexamethasone Repurposed for COVID-19: a Comprehensive Clinical and Pharmacovigilant Reassessment
por: Kelleni, Mina T.
Publicado: (2021) -
Intracranial hemorrhage in coronavirus disease 2019 (COVID-19) patients
por: Cheruiyot, Isaac, et al.
Publicado: (2020) -
The Fear Returns: Messaging in the Age of Coronavirus Disease 2019 (COVID-19)
por: Sindhu, Kunal K., et al.
Publicado: (2020) -
Management and Perspective of Coronavirus Disease 2019 (COVID-19), Pregnancy, and Hypercoagulability
por: Nasir, Umair, et al.
Publicado: (2021)